speb/financial-data huggingface dataset:
Financial ratios for HSHP.OL — quarterly report dated 2025-12-31
Total revenue: 4189054.726368159
Gross profit: 2706467.6616915422
Operating income: 2587064.676616915
Net income: 1343283.5820895522
Capital expenditures: 0
Operating cash flow: 2457711.4427860696
Depreciation & amortization: 726368.15920398
Net tangible assets: 16089552.238805968
Owner earnings: 2069651.7412935323
Return on net tangible assets (%): 12.863327149041437
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.102589641434264
P/E ratio: 239.2446022116383
Shares outstanding: 47145000
Book value: 16089552.23880598
P/B ratio: 26.672065342525986
Market cap (USD): 429141588.64541835
Debt to equity: 4.262213976499688
Current ratio: 1.0846994535519126
Quick ratio: 1.0382513661202186
Effective tax rate (%): 0
Interest coverage ratio: 2.047244094488189
COGS to revenue (%): 35.39192399049881
SG&A to revenue (%): 2.8503562945368173
Free cash flow (dilution-adjusted): 2457711.4427860696
Buyback yield (%): 0
Retained earnings: 3711442.7860696516
Inventory turnover: 8.76470588235294
Receivables turnover: 60.14285714285714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1427535355977274
FCF margin (%): 58.66983372921615
Revenue growth (%): 10.308090156079759
Rule of 40 score: 68.97792388529591
Financial ratios for HYL.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.65909090909091
Shares outstanding: 28000374
Market cap (USD): 550461897.9545455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYL.BR — annual report dated 2022-12-31
Total revenue: 957446.8085106383
Gross profit: 857446.8085106383
Operating income: -12242553.191489363
Net income: -12665957.446808511
Capital expenditures: 107446.80851063831
Operating cash flow: -13851063.829787236
Depreciation & amortization: 208510.63829787236
Net tangible assets: 53512765.95744681
Owner earnings: -12564893.617021278
Return on net tangible assets (%): -23.480179714524276
Buffett classification: The Gruesome
Stock price: 12.340425531914894
Shares outstanding: 28000374
Book value: 57350000.00000001
P/B ratio: 6.025048477990687
Market cap (USD): 345536530.212766
Debt to equity: 0.016416553822181823
Current ratio: 8.628031878031878
Quick ratio: 8.628031878031878
Interest coverage ratio: -52.54794520547945
COGS to revenue (%): 10.444444444444443
R&D to revenue (%): 1141.3333333333335
SG&A to revenue (%): 390.7777777777778
Free cash flow (dilution-adjusted): -15232978.723404257
Buyback yield (%): 0
Retained earnings: -69554255.31914894
Receivables turnover: 0.2180760843227526
Capitalized R&D asset: 10927659.574468086
ROCI (R&D-adjusted, %): -7.144171214815723
FCF margin (%): -1591.0000000000002
Rule of 40 score: -1591.0000000000002
Financial ratios for HYL.BR — annual report dated 2023-12-31
Total revenue: 2318888.888888889
Gross profit: 2215555.5555555555
Operating income: -17606666.666666668
Net income: -17088888.888888888
Capital expenditures: 331111.1111111111
Operating cash flow: -14231111.11111111
Depreciation & amortization: 386666.6666666667
Net tangible assets: 39156666.666666664
Owner earnings: -17033333.333333332
Return on net tangible assets (%): -43.500468204647994
Buffett classification: The Gruesome
Stock price: 14.166666666666666
Shares outstanding: 28000374
Book value: 43410000
P/B ratio: 9.137801543423175
Market cap (USD): 396671965
Debt to equity: 0.04481814226112775
Current ratio: 5.223849681905607
Quick ratio: 5.223849681905607
Interest coverage ratio: -304.7307692307693
COGS to revenue (%): 4.456157163392429
R&D to revenue (%): 690.9918543363679
SG&A to revenue (%): 265.7402970771442
Free cash flow (dilution-adjusted): -15664444.444444444
Buyback yield (%): 0
Retained earnings: -89734444.44444445
Receivables turnover: 0.585413744740533
Capitalized R&D asset: 23344865.248226948
ROCI (R&D-adjusted, %): -15.355938312678575
Rosenberg metric: 0.12428175839390791
FCF margin (%): -675.5150934355534
Revenue growth (%): 142.19506172839507
Rule of 40 score: -533.3200317071583
Financial ratios for HYL.BR — annual report dated 2024-12-31
Total revenue: 8810416.666666668
Gross profit: 8573958.333333334
Operating income: -6634375
Net income: -6606250
Capital expenditures: 31250
Operating cash flow: -7491666.666666667
Depreciation & amortization: 675000
Net tangible assets: 29484375
Owner earnings: -5962500
Return on net tangible assets (%): -20.222575516693166
Buffett classification: The Gruesome
Stock price: 6.8125
Shares outstanding: 28000374
Book value: 33482291.66666667
P/B ratio: 5.6971174426780316
Market cap (USD): 190752547.875
Debt to equity: 0.056497526677659206
Current ratio: 4.148003351019269
Quick ratio: 4.148003351019269
Interest coverage ratio: -82.71428571428571
COGS to revenue (%): 2.6838496098368405
R&D to revenue (%): 121.364388744384
SG&A to revenue (%): 66.52873019626388
Free cash flow (dilution-adjusted): -7193750.000000001
Buyback yield (%): 0
Retained earnings: -90073958.33333334
Receivables turnover: 1.7406873842354393
Capitalized R&D asset: 25034469.326241136
ROCI (R&D-adjusted, %): -14.001944332123243
Rosenberg metric: 0.3968214756258235
FCF margin (%): -81.65050839441949
Revenue growth (%): 279.94130330618117
Rule of 40 score: 198.29079491176168
Financial ratios for HYL.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 29484375
Buffett classification: The Gruesome
Stock price: 6.8125
Shares outstanding: 28000374
Book value: 33482291.66666667
P/B ratio: 5.6971174426780316
Market cap (USD): 190752547.875
Debt to equity: 0.056497526677659206
Current ratio: 4.148003351019269
Quick ratio: 4.148003351019269
Buyback yield (%): 0
Retained earnings: -90073958.33333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYL.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 29327058.82352941
Buffett classification: The Gruesome
Stock price: 7.529411764705883
Shares outstanding: 28000374
Book value: 33987058.823529415
P/B ratio: 6.203135920246461
Market cap (USD): 210826345.41176474
Debt to equity: 0.057080549690193494
Current ratio: 3.823687539531942
Quick ratio: 3.804079696394687
Buyback yield (%): 0
Retained earnings: -105911764.70588236
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBO — quarterly report dated 2024-09-30
Gross profit: 0
Capital expenditures: 0
Depreciation & amortization: 2000
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 107821231
Market cap (USD): 215642462
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 107821231
Market cap (USD): 156340784.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -3397000
Net income: -24708000
Capital expenditures: 0
Operating cash flow: -2854000
Depreciation & amortization: 1119000
Net tangible assets: -13549000
Owner earnings: -23589000
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 107821231
Book value: 7237000
P/B ratio: 21.602982582561836
Market cap (USD): 156340784.95
Debt to equity: 1.2267514163327347
Current ratio: 0.2501788451711804
Quick ratio: 0.2501788451711804
Interest coverage ratio: -3.1896713615023473
Free cash flow (dilution-adjusted): -2873000
Buyback yield (%): 0
Retained earnings: -37669000
Receivables turnover: 0
Capitalized R&D asset: 1811530
ROCI (R&D-adjusted, %): -33.954368641167605
Rule of 40 score: 0
Financial ratios for IBO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1010000
Net income: -1267000
Capital expenditures: 0
Operating cash flow: -682000
Depreciation & amortization: 283000
Net tangible assets: -14009000
Owner earnings: -984000
Buffett classification: The Gruesome
Stock price: 0.87
Shares outstanding: 107821231
Book value: 6810000
P/B ratio: 13.774518497797356
Market cap (USD): 93804470.97
Debt to equity: 1.3422907488986784
Current ratio: 0.21889100571543166
Quick ratio: 0.1698586182693272
Interest coverage ratio: -3.726937269372694
Free cash flow (dilution-adjusted): -713000
Buyback yield (%): 0
Retained earnings: -38936000
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 103000
ROCI (R&D-adjusted, %): -9.245981075860263
Rule of 40 score: 0
Financial ratios for IBO — quarterly report dated 2025-06-30
Total revenue: 7000
Gross profit: -4000
Operating income: -1153000
Net income: -14346000
Capital expenditures: 0
Operating cash flow: -694000
Depreciation & amortization: 288000
Net tangible assets: -27906000
Owner earnings: -14058000
Buffett classification: The Gruesome
Stock price: 0.65
Shares outstanding: 107821231
Book value: -7380000
Market cap (USD): 70083800.15
Debt to equity: -3.0287262872628724
Current ratio: 0.06391334369066114
Quick ratio: 0.04293975487657518
Interest coverage ratio: -4.434615384615385
COGS to revenue (%): 157.14285714285714
R&D to revenue (%): 1071.4285714285713
SG&A to revenue (%): 9657.142857142857
Free cash flow (dilution-adjusted): -667000
Buyback yield (%): 0
Retained earnings: -53283000
Inventory turnover: 0.02263374485596708
Receivables turnover: 0.035
Capitalized R&D asset: 144010
FCF margin (%): -9528.57142857143
Rule of 40 score: -9528.57142857143
Financial ratios for IBO — quarterly report dated 2025-09-30
Total revenue: 18000
Gross profit: 17000
Operating income: -948000
Net income: -1470000
Capital expenditures: 0
Operating cash flow: -613000
Depreciation & amortization: 288000
Net tangible assets: -29087000
Owner earnings: -1182000
Buffett classification: The Gruesome
Stock price: 0.67
Shares outstanding: 107821231
Book value: -8853000
Market cap (USD): 72240224.77000001
Debt to equity: -2.584547610979329
Current ratio: 0.038540747278611356
Quick ratio: 0.018156600680872527
Interest coverage ratio: -3.618320610687023
COGS to revenue (%): 5.555555555555555
R&D to revenue (%): 288.88888888888886
SG&A to revenue (%): 2866.666666666667
Free cash flow (dilution-adjusted): -614000
Buyback yield (%): 0
Retained earnings: -54752000
Inventory turnover: 0.002061855670103093
Receivables turnover: 0.08411214953271028
Capitalized R&D asset: 136240
Rosenberg metric: 0.28
FCF margin (%): -3411.1111111111113
Revenue growth (%): 157.14285714285714
Rule of 40 score: -3253.968253968254
Financial ratios for IBO — quarterly report dated 2025-12-31
Total revenue: 7000
Gross profit: -415000
Operating income: -1158000
Net income: 5245000
Capital expenditures: 0
Operating cash flow: 99000
Depreciation & amortization: 286000
Net tangible assets: -4385000
Owner earnings: 5531000
Return on net tangible assets (%): -126.1345496009122
Buffett classification: The Gruesome
Stock price: 0.5
P/E ratio: 2.5696194232602476
Shares outstanding: 107821231
Book value: 15555000
P/B ratio: 3.4658062037929924
Market cap (USD): 53910615.5
Debt to equity: 0
Current ratio: 0.35370051635111877
Quick ratio: 0.29948364888123924
Effective tax rate (%): -97.17514124293785
COGS to revenue (%): 6028.571428571428
R&D to revenue (%): 1571.4285714285713
SG&A to revenue (%): 3928.5714285714284
Free cash flow (dilution-adjusted): 91000
Buyback yield (%): 0
Retained earnings: -49507000
Inventory turnover: 6.698412698412699
Receivables turnover: 0.034482758620689655
Capitalized R&D asset: 169590
ROCI (R&D-adjusted, %): -6.866679786675961
Rosenberg metric: -8.307692307692308
FCF margin (%): 1300
Revenue growth (%): -61.111111111111114
Rule of 40 score: 1238.888888888889
Financial ratios for IBO — annual report dated 2025-12-31
Total revenue: 32000
Gross profit: -392000
Operating income: -4270000
Net income: -11838000
Capital expenditures: 0
Operating cash flow: -1890000
Depreciation & amortization: 1145000
Net tangible assets: -4385000
Owner earnings: -10693000
Buffett classification: The Gruesome
Stock price: 0.5
Shares outstanding: 107821231
Book value: 15555000
P/B ratio: 3.4658062037929924
Market cap (USD): 53910615.5
Debt to equity: 0
Current ratio: 0.35370051635111877
Quick ratio: 0.29948364888123924
Interest coverage ratio: -5.384615384615385
COGS to revenue (%): 1325
R&D to revenue (%): 1062.5
SG&A to revenue (%): 6175
Free cash flow (dilution-adjusted): -1903000
Buyback yield (%): 0
Retained earnings: -49507000
Inventory turnover: 6.73015873015873
Receivables turnover: 0.15763546798029557
Capitalized R&D asset: 1082310
ROCI (R&D-adjusted, %): -27.114473949768676
Rosenberg metric: -1.410071942446043
FCF margin (%): -5946.875
Rule of 40 score: -5946.875
Financial ratios for IEQ.AX — annual report dated 2021-06-30
Capital expenditures: 81954.88721804511
Buffett classification: The Gruesome
Stock price: 0.03007518796992481
Shares outstanding: 128223577
Market cap (USD): 3856348.1804511277
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEQ.AX — annual report dated 2022-06-30
Total revenue: 3887586.206896552
Gross profit: 1647586.206896552
Operating income: -1299310.3448275863
Net income: -963448.275862069
Capital expenditures: 238620.68965517243
Depreciation & amortization: 903448.275862069
Net tangible assets: 4472413.793103448
Owner earnings: -298620.6896551724
Return on net tangible assets (%): -6.6769468003084045
Buffett classification: The Gruesome
Stock price: 0.027586206896551727
Shares outstanding: 128223577
Book value: 4488275.862068966
P/B ratio: 0.7880981991395205
Market cap (USD): 3537202.1241379315
Debt to equity: 3.8520282728948985
Current ratio: 0.11892361111111112
Quick ratio: 0.0834703947368421
Interest coverage ratio: -2.2216981132075473
COGS to revenue (%): 57.61930104665603
SG&A to revenue (%): 42.06138016675537
Free cash flow (dilution-adjusted): -6896.551724137931
Buyback yield (%): 0
Retained earnings: -8500000
Inventory turnover: 4.185567010309279
Receivables turnover: 7.586810228802154
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.81109751121991
FCF margin (%): -0.17739932588256166
Rule of 40 score: -0.17739932588256166
Financial ratios for IEQ.AX — annual report dated 2023-06-30
Total revenue: 2526490.0662251655
Gross profit: 1294039.7350993378
Operating income: -364900.66225165565
Net income: -430463.5761589404
Capital expenditures: 734437.0860927153
Depreciation & amortization: 690066.2251655629
Net tangible assets: 8313245.033112583
Owner earnings: -474834.4370860927
Return on net tangible assets (%): -5.711782044132876
Buffett classification: The Gruesome
Stock price: 0.019867549668874173
Shares outstanding: 128223577
Book value: -189403.9735099338
Market cap (USD): 2547488.284768212
Debt to equity: -46.730769230769226
Current ratio: 0.940047680462735
Quick ratio: 0.910384179466135
Interest coverage ratio: -3.7739726027397267
COGS to revenue (%): 48.78112712975098
SG&A to revenue (%): 37.745740498034074
Free cash flow (dilution-adjusted): -273509.93377483444
Buyback yield (%): 0
Retained earnings: -8592715.23178808
Inventory turnover: 2.4519104084321475
Receivables turnover: 3.67533718689788
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.34719502361479
FCF margin (%): -10.825688073394495
Revenue growth (%): -35.01134298338673
Rule of 40 score: -45.83703105678123
Financial ratios for IEQ.AX — annual report dated 2024-06-30
Total revenue: 1622000
Gross profit: 1006000
Operating income: -151333.33333333334
Net income: 311333.3333333333
Capital expenditures: 14250000
Depreciation & amortization: 250666.66666666666
Net tangible assets: 4212666.666666667
Owner earnings: -13688000
Return on net tangible assets (%): -324.92482987814526
Buffett classification: The Gruesome
Stock price: 0.02666666666666667
P/E ratio: 10.982747494646683
Shares outstanding: 128223577
Book value: 4220666.666666667
P/B ratio: 0.8101315874269467
Market cap (USD): 3419295.3866666667
Debt to equity: 0.8767967145790554
Current ratio: 0.9028303989302429
Quick ratio: 0.7341207934031646
Interest coverage ratio: -1.2010582010582012
COGS to revenue (%): 37.97780517879161
SG&A to revenue (%): 55.610357583230574
Free cash flow (dilution-adjusted): -2230000
Buyback yield (%): 0
Retained earnings: -3868000
Inventory turnover: 1.2206076618229855
Receivables turnover: 7.555900621118012
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3423795273965538
FCF margin (%): -137.4845869297164
Revenue growth (%): -35.8002621231979
Rule of 40 score: -173.2848490529143
Financial ratios for IMI.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.21702702702702703
Shares outstanding: 236835877
Market cap (USD): 51399786.27864865
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMI.L — annual report dated 2022-12-31
Total revenue: 2468674698.795181
Gross profit: 1128795180.7228916
Operating income: 359277108.43373495
Net income: 272650602.4096386
Capital expenditures: 65421686.746987954
Operating cash flow: 341807228.91566265
Depreciation & amortization: 147228915.66265061
Net tangible assets: -130722891.56626506
Owner earnings: 354457831.3253013
Return on net tangible assets (%): -271.152073732719
Capex to operating income (%): 18.209255533199194
Buffett classification: The Great
Stock price: 0.14626506024096386
P/E ratio: 0.1270520347671233
Shares outstanding: 236835877
Book value: 1091084337.3493974
P/B ratio: 0.031748979094302125
Market cap (USD): 34640813.816626504
Debt to equity: 1.0435070671378095
Current ratio: 1.287022341594433
Quick ratio: 0.77707239653278
Effective tax rate (%): 20.707778556412052
Interest coverage ratio: 12.529411764705882
COGS to revenue (%): 54.27525622254758
Free cash flow (dilution-adjusted): 241807228.91566265
Buyback yield (%): 0
Retained earnings: 709879518.0722892
Inventory turnover: 2.662437155853483
Receivables turnover: 5.581585399073822
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.43146080551821
FCF margin (%): 9.79502196193265
Rule of 40 score: 9.79502196193265
Financial ratios for IMI.L — annual report dated 2023-12-31
Total revenue: 2779746835.443038
Gross profit: 1281392405.063291
Operating income: 403291139.2405063
Net income: 300379746.835443
Capital expenditures: 74430379.74683544
Operating cash flow: 459746835.4430379
Depreciation & amortization: 157468354.43037975
Net tangible assets: 91772151.89873417
Owner earnings: 383417721.5189873
Return on net tangible assets (%): 417.7931034482759
Capex to operating income (%): 18.455743879472696
Buffett classification: The Great
Stock price: 0.20455696202531645
P/E ratio: 0.16128393477960387
Shares outstanding: 236835877
Book value: 1304050632.9113922
P/B ratio: 0.03715072580392157
Market cap (USD): 48446427.497721516
Debt to equity: 0.7232576198796351
Current ratio: 1.504988913525499
Quick ratio: 0.8989745011086475
Effective tax rate (%): 21.527777777777775
Interest coverage ratio: 10.344155844155845
COGS to revenue (%): 53.90255009107467
Free cash flow (dilution-adjusted): 342278481.01265824
Buyback yield (%): 0
Retained earnings: 944303797.4683543
Inventory turnover: 2.706837411388063
Receivables turnover: 5.454545454545455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.218206770356815
FCF margin (%): 12.313296903460838
Revenue growth (%): 12.60077469095761
Rule of 40 score: 24.91407159441845
Financial ratios for IMI.L — annual report dated 2024-12-31
Total revenue: 2762500000
Gross profit: 1305750000
Operating income: 445250000
Net income: 310625000
Capital expenditures: 74625000
Operating cash flow: 464500000
Depreciation & amortization: 148750000
Net tangible assets: 200250000
Owner earnings: 384750000
Return on net tangible assets (%): 192.13483146067415
Capex to operating income (%): 16.760247052217856
Buffett classification: The Great
Stock price: 0.222
P/E ratio: 0.16926378975935616
Shares outstanding: 236835877
Book value: 1356375000
P/B ratio: 0.03876329532319602
Market cap (USD): 52577564.694
Debt to equity: 0.6409547507142199
Current ratio: 1.362009716791089
Quick ratio: 0.8313781253703045
Effective tax rate (%): 24.78813559322034
Interest coverage ratio: 14.538775510204081
COGS to revenue (%): 52.73303167420814
Free cash flow (dilution-adjusted): 336625000
Buyback yield (%): 238.69496567672277
Retained earnings: 1036875000
Inventory turnover: 2.6025011165698975
Receivables turnover: 5.293413173652695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.63245475525325
FCF margin (%): 12.185520361990951
Revenue growth (%): -0.6204462659380696
Rule of 40 score: 11.565074096052882
Financial ratios for IMI.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 200250000
Buffett classification: The Gruesome
Stock price: 0.222
Shares outstanding: 236835877
Book value: 1356375000
P/B ratio: 0.03876329532319602
Market cap (USD): 52577564.694
Debt to equity: 0.6409547507142199
Current ratio: 1.362009716791089
Quick ratio: 0.8313781253703045
Buyback yield (%): 0
Retained earnings: 1036875000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMI.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 38767123.28767123
Buffett classification: The Gruesome
Stock price: 0.283013698630137
Shares outstanding: 236835877
Book value: 1253150684.931507
P/B ratio: 0.053487420406864876
Market cap (USD): 67027797.51808219
Debt to equity: 0.939221687800612
Current ratio: 1.1956059532246635
Quick ratio: 0.7340285511795079
Buyback yield (%): 0
Retained earnings: 957123287.6712329
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITGR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.59
Shares outstanding: 33954839
Market cap (USD): 2906194670.01
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITGR — annual report dated 2022-12-31
Total revenue: 1331277000
Gross profit: 345761000
Operating income: 127949000
Net income: 66377000
Capital expenditures: 74089000
Operating cash flow: 116381000
Depreciation & amortization: 91991000
Net tangible assets: -384625000
Owner earnings: 84279000
Return on net tangible assets (%): -21.911992200194994
Capex to operating income (%): 57.90510281440261
Buffett classification: The Good
Stock price: 68.46
P/E ratio: 35.02038775389065
Shares outstanding: 33954839
Book value: 1417456000
P/B ratio: 1.6399438698202977
Market cap (USD): 2324548277.9399996
Debt to equity: 0.7116771173143999
Current ratio: 2.495164289034288
Quick ratio: 1.5621402266795381
Effective tax rate (%): 13.001630846292736
Interest coverage ratio: 3.4334898698510665
COGS to revenue (%): 74.02786948170817
R&D to revenue (%): 4.489073273255679
SG&A to revenue (%): 11.872059684047723
Free cash flow (dilution-adjusted): 20630000
Buyback yield (%): 0
Retained earnings: 680701000
Inventory turnover: 4.720672906507764
Receivables turnover: 4.463552999949708
Capitalized R&D asset: 59762000
ROCI (R&D-adjusted, %): 6.378900109844045
FCF margin (%): 1.5496399321854128
Rule of 40 score: 1.5496399321854128
Financial ratios for ITGR — annual report dated 2023-12-31
Total revenue: 1555656000
Gross profit: 409889000
Operating income: 174751000
Net income: 90650000
Capital expenditures: 119938000
Operating cash flow: 180213000
Depreciation & amortization: 98841000
Net tangible assets: -254563000
Owner earnings: 69553000
Return on net tangible assets (%): -27.322509555591346
Capex to operating income (%): 68.63365588751996
Buffett classification: The Good
Stock price: 99.08
P/E ratio: 37.112470470159955
Shares outstanding: 33954839
Book value: 1519042000
P/B ratio: 2.2147152271760753
Market cap (USD): 3364245448.12
Debt to equity: 0.6930295541532098
Current ratio: 2.7952699247405746
Quick ratio: 1.7584638569211066
Effective tax rate (%): 15.409652502324874
Interest coverage ratio: 3.408113115553389
COGS to revenue (%): 73.65169420488849
R&D to revenue (%): 3.9833356474696204
SG&A to revenue (%): 11.131702638629621
Free cash flow (dilution-adjusted): 36992000
Buyback yield (%): 0
Retained earnings: 771351000
Inventory turnover: 5.00112177108886
Receivables turnover: 4.905049282052253
Capitalized R&D asset: 102007540
ROCI (R&D-adjusted, %): 6.9462851691890775
Rosenberg metric: 1.073056457280546
FCF margin (%): 2.3779035982248002
Revenue growth (%): 16.85441872728215
Rule of 40 score: 19.232322325506953
Financial ratios for ITGR — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 10061000
Buffett classification: The Gruesome
Stock price: 130
Shares outstanding: 33954839
Market cap (USD): 4414129070
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITGR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 132.52
Shares outstanding: 33954839
Market cap (USD): 4499695264.280001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITGR — annual report dated 2024-12-31
Total revenue: 1716596000
Gross profit: 459014000
Operating income: 220387000
Net income: 119896000
Capital expenditures: 105357000
Operating cash flow: 205205000
Depreciation & amortization: 111031000
Net tangible assets: -176800000
Owner earnings: 125570000
Return on net tangible assets (%): -71.0237556561086
Capex to operating income (%): 47.80545131972394
Buffett classification: The Good
Stock price: 132.52
P/E ratio: 37.52998652398746
Shares outstanding: 33954839
Book value: 1619215000
P/B ratio: 2.778936252616237
Market cap (USD): 4499695264.280001
Debt to equity: 0.6815203663503612
Current ratio: 2.954219911697253
Quick ratio: 1.8663881711294916
Effective tax rate (%): 17.965208080616417
Interest coverage ratio: 4.212531299577575
COGS to revenue (%): 73.26021964399311
R&D to revenue (%): 3.112264038830336
SG&A to revenue (%): 10.788910145427346
Free cash flow (dilution-adjusted): 75081000
Buyback yield (%): 0
Retained earnings: 891247000
Inventory turnover: 5.0888291802562255
Receivables turnover: 4.918035417042697
Capitalized R&D asset: 114664350
ROCI (R&D-adjusted, %): 7.264544543394163
Rosenberg metric: 0.7927606629334969
FCF margin (%): 4.3738305343831625
Revenue growth (%): 10.345474835053508
Rule of 40 score: 14.719305369436672
Financial ratios for ITGR — quarterly report dated 2025-03-31
Total revenue: 437392000
Gross profit: 120318000
Operating income: 56126000
Net income: -22487000
Capital expenditures: 25213000
Operating cash flow: 31276000
Depreciation & amortization: 29832000
Net tangible assets: -331889000
Owner earnings: -17868000
Capex to operating income (%): 44.922139471902504
Buffett classification: The Good
Stock price: 118.01
Shares outstanding: 33954839
Book value: 1606704000
P/B ratio: 2.493932018834832
Market cap (USD): 4007010550.3900003
Debt to equity: 0.8430980441948237
Current ratio: 3.402096868747063
Quick ratio: 2.1419262316923686
Interest coverage ratio: 4.343109185173721
COGS to revenue (%): 72.49195229908183
R&D to revenue (%): 3.2467443391740134
SG&A to revenue (%): 8.814061528331566
Free cash flow (dilution-adjusted): -822000
Buyback yield (%): 0
Retained earnings: 868760000
Inventory turnover: 1.219032460217683
Receivables turnover: 1.15356638930281
Capitalized R&D asset: 14201000
ROCI (R&D-adjusted, %): 2.1121659060271867
FCF margin (%): -0.18793210666861762
Rule of 40 score: -0.18793210666861762
Financial ratios for ITGR — quarterly report dated 2025-06-30
Total revenue: 476494000
Gross profit: 129152000
Operating income: 62902000
Net income: 37009000
Capital expenditures: 19001000
Operating cash flow: 43862000
Depreciation & amortization: 32286000
Net tangible assets: -251379000
Owner earnings: 50294000
Return on net tangible assets (%): -20.007240063808034
Capex to operating income (%): 30.207306603923563
Buffett classification: The Good
Stock price: 122.97
P/E ratio: 287.5242082240738
Shares outstanding: 33954839
Book value: 1703537000
P/B ratio: 2.4510336739560104
Market cap (USD): 4175426551.83
Debt to equity: 0.775510012403605
Current ratio: 3.4135536731009584
Quick ratio: 2.180220339767625
Effective tax rate (%): 18.83279235020616
Interest coverage ratio: 7.8539143463603445
COGS to revenue (%): 72.89535649976705
R&D to revenue (%): 2.988495133202097
SG&A to revenue (%): 8.247952754914017
Free cash flow (dilution-adjusted): 19205000
Buyback yield (%): 0
Retained earnings: 905769000
Inventory turnover: 1.3036552731039608
Receivables turnover: 1.175118253157939
Capitalized R&D asset: 23754670
ROCI (R&D-adjusted, %): 2.1286225545079094
Rosenberg metric: 0.62206886838955
FCF margin (%): 4.030480971428811
Revenue growth (%): 8.939806855177963
Rule of 40 score: 12.970287826606775
Financial ratios for ITGR — quarterly report dated 2025-09-30
Total revenue: 467691000
Gross profit: 126160000
Operating income: 65901000
Net income: 39678000
Capital expenditures: 19336000
Operating cash flow: 65595000
Depreciation & amortization: 33040000
Net tangible assets: -190679000
Owner earnings: 53382000
Return on net tangible assets (%): -27.995741534201457
Capex to operating income (%): 29.34098116872278
Buffett classification: The Good
Stock price: 103.33
P/E ratio: 64.73345966549815
Shares outstanding: 33954839
Book value: 1745837000
P/B ratio: 2.009668436325957
Market cap (USD): 3508553513.87
Debt to equity: 0.7510174202975421
Current ratio: 3.70850391524204
Quick ratio: 2.452490456150719
Effective tax rate (%): 13.728474517307356
Interest coverage ratio: 8.497872340425532
COGS to revenue (%): 73.02492457626938
R&D to revenue (%): 2.3410756247180293
SG&A to revenue (%): 7.79980799288419
Free cash flow (dilution-adjusted): 40378000
Buyback yield (%): 0
Retained earnings: 945447000
Inventory turnover: 1.2959459356904885
Receivables turnover: 1.12083274418783
Capitalized R&D asset: 25176130
ROCI (R&D-adjusted, %): 1.9833999941350873
Rosenberg metric: -0.2101123595505618
FCF margin (%): 8.633478087027546
Revenue growth (%): -1.847452433818684
Rule of 40 score: 6.7860256532088625
Financial ratios for ITGR — annual report dated 2025-12-31
Total revenue: 1853637000
Gross profit: 500386000
Operating income: 239139000
Net income: 102808000
Capital expenditures: 91032000
Operating cash flow: 196148000
Depreciation & amortization: 130667000
Net tangible assets: -189700000
Owner earnings: 142443000
Return on net tangible assets (%): -75.08856088560886
Capex to operating income (%): 38.06656379762398
Buffett classification: The Good
Stock price: 78.43
P/E ratio: 25.903412407302934
Shares outstanding: 33954839
Book value: 1746643000
P/B ratio: 1.5246836490170002
Market cap (USD): 2663078022.7700005
Debt to equity: 0.7514975870856265
Current ratio: 3.3187971091315758
Quick ratio: 2.2252877724195295
Effective tax rate (%): 17.995789339372866
Interest coverage ratio: 6.583498513379584
COGS to revenue (%): 73.00517846806036
R&D to revenue (%): 2.6703718149777975
SG&A to revenue (%): 11.423380090060784
Free cash flow (dilution-adjusted): 81892000
Buyback yield (%): 1.87805237294467
Retained earnings: 994055000
Inventory turnover: 5.33324006163814
Receivables turnover: 4.04172690106296
Capitalized R&D asset: 105742860
ROCI (R&D-adjusted, %): 7.114935828967134
Rosenberg metric: 0.7743940102948058
FCF margin (%): 4.417909223866377
Revenue growth (%): 7.98329950669814
Rule of 40 score: 12.401208730564516
Financial ratios for ITGR — quarterly report dated 2025-12-31
Total revenue: 472060000
Gross profit: 124756000
Operating income: 54547000
Net income: 48608000
Capital expenditures: 26527000
Operating cash flow: 55415000
Depreciation & amortization: 35509000
Net tangible assets: -189700000
Owner earnings: 57590000
Return on net tangible assets (%): -30.35846072746442
Capex to operating income (%): 48.631455442095806
Buffett classification: The Good
Stock price: 78.43
P/E ratio: 25.903412407302934
Shares outstanding: 33954839
Book value: 1746643000
P/B ratio: 1.5246836490170002
Market cap (USD): 2663078022.7700005
Debt to equity: 0.7514975870856265
Current ratio: 3.3187971091315758
Quick ratio: 2.2252877724195295
Effective tax rate (%): -3.847715085350482
Interest coverage ratio: 8.057163958641064
COGS to revenue (%): 73.57200355886964
R&D to revenue (%): 2.1414650679998304
SG&A to revenue (%): 20.636359784773123
Free cash flow (dilution-adjusted): 23131000
Buyback yield (%): 0
Retained earnings: 994055000
Inventory turnover: 1.3687450490464612
Receivables turnover: 1.0292940855819024
Capitalized R&D asset: 22144030
ROCI (R&D-adjusted, %): 1.652461336474174
Rosenberg metric: -0.12823088866563156
FCF margin (%): 4.9000127102486974
Revenue growth (%): 0.934163796181667
Rule of 40 score: 5.834176506430365
Financial ratios for IVZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.88
Shares outstanding: 443296629
Market cap (USD): 8369440355.5199995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IVZ — annual report dated 2022-12-31
Total revenue: 6048900000
Gross profit: 2437600000
Operating income: 1338900000
Net income: 925500000
Capital expenditures: 192900000
Operating cash flow: 703200000
Depreciation & amortization: 195300000
Net tangible assets: -485300000
Owner earnings: 927900000
Return on net tangible assets (%): -191.20131877189368
Capex to operating income (%): 14.407349316603183
Buffett classification: The Great
Stock price: 15.35
P/E ratio: 7.35235359821718
Shares outstanding: 443296629
Book value: 16842200000
P/B ratio: 0.40402104565614944
Market cap (USD): 6804603255.15
Debt to equity: 0.5081402667109998
Current ratio: 5.823654626488392
Quick ratio: 5.823654626488392
Effective tax rate (%): 25.82351526809329
Interest coverage ratio: 15.714788732394366
COGS to revenue (%): 59.70176395708311
SG&A to revenue (%): 9.724082064507597
Free cash flow (dilution-adjusted): 404100000
Buyback yield (%): 3.596095037793733
Retained earnings: 7518300000
Receivables turnover: 0.8262847307597738
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.738881908436123
FCF margin (%): 6.680553489064127
Rule of 40 score: 6.680553489064127
Financial ratios for IVZ — annual report dated 2023-12-31
Total revenue: 5716400000
Gross profit: 2005400000
Operating income: -393200000
Net income: -96900000
Capital expenditures: 164300000
Operating cash flow: 1300800000
Depreciation & amortization: 1298800000
Net tangible assets: 58000000
Owner earnings: 1037600000
Buffett classification: The Gruesome
Stock price: 15.99
Shares outstanding: 443296629
Book value: 15916000000
P/B ratio: 0.44535769651357127
Market cap (USD): 7088313097.71
Debt to equity: 0.5682960542849962
Current ratio: 7.747808066315957
Quick ratio: 7.747808066315957
Interest coverage ratio: -5.577304964539007
COGS to revenue (%): 84.44125673500805
SG&A to revenue (%): 11.365544748443076
Free cash flow (dilution-adjusted): 1021900000
Buyback yield (%): 2.64519918089644
Retained earnings: 6826700000
Receivables turnover: 0.7339256368118324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4205612878984941
FCF margin (%): 17.87663564481142
Revenue growth (%): -5.496867198994859
Rule of 40 score: 12.379768445816559
Financial ratios for IVZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.36
Shares outstanding: 443296629
Market cap (USD): 7252332850.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IVZ — annual report dated 2024-12-31
Total revenue: 6067000000
Gross profit: 2027200000
Operating income: 832100000
Net income: 774800000
Capital expenditures: 69100000
Operating cash flow: 1190000000
Depreciation & amortization: 179600000
Net tangible assets: 492500000
Owner earnings: 885300000
Return on net tangible assets (%): 179.75634517766497
Capex to operating income (%): 8.304290349717581
Buffett classification: The Great
Stock price: 16.48
P/E ratio: 9.4289215874032
Shares outstanding: 443296629
Book value: 15668800000
P/B ratio: 0.46624683740426837
Market cap (USD): 7305528445.92
Debt to equity: 0.481619524149903
Current ratio: 10.11813583815029
Quick ratio: 10.11813583815029
Effective tax rate (%): 25.156669650850493
Interest coverage ratio: 14.346551724137932
COGS to revenue (%): 66.58645129388495
SG&A to revenue (%): 11.142244931597164
Free cash flow (dilution-adjusted): 1016300000
Buyback yield (%): 1.0854793131944829
Retained earnings: 6990400000
Receivables turnover: 0.8784987185242032
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.178562560880112
FCF margin (%): 16.75127740234053
Revenue growth (%): 6.133230704639284
Rule of 40 score: 22.884508106979816
Financial ratios for IVZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.48
Shares outstanding: 443296629
Market cap (USD): 7305528445.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IVZ — quarterly report dated 2025-03-31
Total revenue: 1529200000
Gross profit: 555600000
Operating income: 277300000
Net income: 267300000
Capital expenditures: 23400000
Operating cash flow: -84600000
Depreciation & amortization: 41500000
Net tangible assets: 579100000
Owner earnings: 285400000
Return on net tangible assets (%): 49.28337074771197
Capex to operating income (%): 8.43851424450054
Buffett classification: The Great
Stock price: 14.46
P/E ratio: 5.9952013237373745
Shares outstanding: 443296629
Book value: 15787400000
P/B ratio: 0.40602437737309505
Market cap (USD): 6410069255.34
Debt to equity: 0.061112026046087384
Current ratio: 6.694709331072968
Quick ratio: 6.694709331072968
Effective tax rate (%): 22.499275152218033
Interest coverage ratio: 21.16793893129771
COGS to revenue (%): 63.66727700758567
SG&A to revenue (%): 10.090243264452
Free cash flow (dilution-adjusted): -123200000
Buyback yield (%): 0.6723796309079645
Retained earnings: 7069000000
Receivables turnover: 0.2010967478926397
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0374926574852494
FCF margin (%): -8.05650013078734
Rule of 40 score: -8.05650013078734
Financial ratios for IVZ — quarterly report dated 2025-06-30
Total revenue: 1515500000
Gross profit: 504400000
Operating income: 214200000
Net income: 203400000
Capital expenditures: 17500000
Operating cash flow: 547900000
Depreciation & amortization: 40100000
Net tangible assets: -461500000
Owner earnings: 226000000
Return on net tangible assets (%): -48.97074756229686
Capex to operating income (%): 8.169934640522875
Buffett classification: The Great
Stock price: 15.24
P/E ratio: 14.352752551434035
Shares outstanding: 443296629
Book value: 14958900000
P/B ratio: 0.4516268325852837
Market cap (USD): 6755840625.96
Debt to equity: 0.12593840456183275
Current ratio: 6.661754434976952
Quick ratio: 6.661754434976952
Effective tax rate (%): 28.061224489795915
Interest coverage ratio: 10.347826086956522
COGS to revenue (%): 66.71725503134279
SG&A to revenue (%): 10.709336852523919
Free cash flow (dilution-adjusted): 506700000
Buyback yield (%): 17.39975918737666
Retained earnings: 6961300000
Receivables turnover: 0.18834509842911115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7914251194342531
FCF margin (%): 33.43451006268558
Revenue growth (%): -0.8958932775307351
Rule of 40 score: 32.53861678515485
Financial ratios for IVZ — quarterly report dated 2025-09-30
Total revenue: 1640400000
Gross profit: 560500000
Operating income: 270900000
Net income: 356400000
Capital expenditures: 19800000
Operating cash flow: 606200000
Depreciation & amortization: 38300000
Net tangible assets: -185400000
Owner earnings: 374900000
Return on net tangible assets (%): -202.2114347357066
Capex to operating income (%): 7.308970099667775
Buffett classification: The Great
Stock price: 22.38
P/E ratio: 11.994896091186071
Shares outstanding: 443296629
Book value: 14792300000
P/B ratio: 0.6706853266239867
Market cap (USD): 9920978557.02
Debt to equity: 0.10982741020666158
Current ratio: 6.698302365993851
Quick ratio: 6.698302365993851
Effective tax rate (%): -2.7978079030862415
Interest coverage ratio: 10.540856031128405
COGS to revenue (%): 65.83150451109485
SG&A to revenue (%): 10.44867105584004
Free cash flow (dilution-adjusted): 565500000
Buyback yield (%): 0.2943258049815895
Retained earnings: 7167600000
Receivables turnover: 0.19302911204725706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0054671580799253
FCF margin (%): 34.47329919531821
Revenue growth (%): 8.241504453975585
Rule of 40 score: 42.7148036492938
Financial ratios for IVZ — quarterly report dated 2025-12-31
Total revenue: 1692000000
Gross profit: 626700000
Operating income: -1458100000
Net income: -995900000
Capital expenditures: 23600000
Operating cash flow: 455800000
Depreciation & amortization: 1803600000
Net tangible assets: -173400000
Owner earnings: 784100000
Buffett classification: The Gruesome
Stock price: 25.86
Shares outstanding: 443296629
Book value: 13004900000
P/B ratio: 0.8814870414951287
Market cap (USD): 11463650825.94
Debt to equity: 0.7523702604402955
Current ratio: 12.002006688963212
Quick ratio: 12.002006688963212
Interest coverage ratio: -63.39565217391304
COGS to revenue (%): 167.4290780141844
SG&A to revenue (%): 10.195035460992907
Free cash flow (dilution-adjusted): 412000000
Buyback yield (%): 5.371761660836398
Retained earnings: 5886800000
Receivables turnover: 0.19257910311859777
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.565904492880864
FCF margin (%): 24.349881796690305
Revenue growth (%): 3.1455742501828823
Rule of 40 score: 27.495456046873187
Financial ratios for IVZ — annual report dated 2025-12-31
Total revenue: 6377100000
Gross profit: 2247200000
Operating income: -695700000
Net income: -174800000
Capital expenditures: 84300000
Operating cash flow: 1525300000
Depreciation & amortization: 1832400000
Net tangible assets: -173400000
Owner earnings: 1573300000
Buffett classification: The Gruesome
Stock price: 25.86
Shares outstanding: 443296629
Book value: 13004900000
P/B ratio: 0.8814870414951287
Market cap (USD): 11463650825.94
Debt to equity: 0.7523702604402955
Current ratio: 12.002006688963212
Quick ratio: 12.002006688963212
Interest coverage ratio: -8.432727272727274
COGS to revenue (%): 91.05079111194743
SG&A to revenue (%): 10.357372473381316
Free cash flow (dilution-adjusted): 1361000000
Buyback yield (%): 16.256601219770562
Retained earnings: 5886800000
Receivables turnover: 0.725825176417027
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6556475932358667
FCF margin (%): 21.341989305483683
Revenue growth (%): 5.111257623207516
Rule of 40 score: 26.4532469286912
Financial ratios for KSCP — annual report dated 2022-12-31
Total revenue: 5631000
Gross profit: -3319000
Operating income: -31968000
Net income: -25643000
Capital expenditures: 111000
Operating cash flow: -24064000
Depreciation & amortization: 1710000
Net tangible assets: -11203000
Owner earnings: -24044000
Buffett classification: The Gruesome
Stock price: 94.5
Shares outstanding: 16916595
Book value: -7803000
Market cap (USD): 1598618227.5
Debt to equity: -1.3761373830577983
Current ratio: 0.9600342563516986
Quick ratio: 0.7164335331620516
Interest coverage ratio: -3.4616134271792096
COGS to revenue (%): 158.9415734327828
R&D to revenue (%): 150.04439708755106
SG&A to revenue (%): 358.7284674125377
Free cash flow (dilution-adjusted): -27714000
Buyback yield (%): 0
Retained earnings: -139340000
Inventory turnover: 3.49609375
Receivables turnover: 3.225085910652921
Capitalized R&D asset: 8449000
ROCI (R&D-adjusted, %): -131.53198148703095
FCF margin (%): -492.1683537559936
Rule of 40 score: -492.1683537559936
Financial ratios for KSCP — annual report dated 2023-12-31
Total revenue: 12797000
Gross profit: -2024000
Operating income: -26139000
Net income: -22118000
Capital expenditures: 457000
Operating cash flow: -24155000
Depreciation & amortization: 2364000
Net tangible assets: 4090000
Owner earnings: -20211000
Return on net tangible assets (%): -494.15647921760393
Buffett classification: The Gruesome
Stock price: 30
Shares outstanding: 16916595
Book value: 7569000
P/B ratio: 67.04952437574316
Market cap (USD): 507497850
Debt to equity: 0.3548685427401242
Current ratio: 1.1824071408004606
Quick ratio: 0.8484019579614166
Interest coverage ratio: -47.439201451905625
COGS to revenue (%): 115.8162069234977
R&D to revenue (%): 49.62881925451278
SG&A to revenue (%): 138.81378448073767
Free cash flow (dilution-adjusted): -27338000
Buyback yield (%): 0
Retained earnings: -161458000
Inventory turnover: 6.388362068965518
Receivables turnover: 4.525106082036775
Capitalized R&D asset: 12011830
ROCI (R&D-adjusted, %): -88.16506139064799
Rosenberg metric: 0.15327257663628832
FCF margin (%): -213.62819410799406
Revenue growth (%): 127.25981175634877
Rule of 40 score: -86.3683823516453
Financial ratios for KSCP — quarterly report dated 2024-09-30
Capital expenditures: 8000
Buffett classification: The Gruesome
Stock price: 7.36
Shares outstanding: 16916595
Market cap (USD): 124506139.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KSCP — quarterly report dated 2024-12-31
Capital expenditures: 31000
Buffett classification: The Gruesome
Stock price: 12.62
Shares outstanding: 16916595
Market cap (USD): 213487428.89999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KSCP — annual report dated 2024-12-31
Total revenue: 10805000
Gross profit: -3699000
Operating income: -29168000
Net income: -31734000
Capital expenditures: 43000
Operating cash flow: -22453000
Depreciation & amortization: 2617000
Net tangible assets: 12618000
Owner earnings: -29160000
Return on net tangible assets (%): -231.09843081312408
Buffett classification: The Gruesome
Stock price: 12.62
Shares outstanding: 16916595
Book value: 15781000
P/B ratio: 13.52813059375198
Market cap (USD): 213487428.89999998
Debt to equity: 0.3629681262277422
Current ratio: 1.8268602540834846
Quick ratio: 1.609437386569873
Interest coverage ratio: -68.95508274231679
COGS to revenue (%): 134.23415085608514
R&D to revenue (%): 65.34937528921796
SG&A to revenue (%): 170.3655714946784
Free cash flow (dilution-adjusted): -24208000
Buyback yield (%): 0.036536109129187234
Retained earnings: -193192000
Inventory turnover: 8.071229827490262
Receivables turnover: 5.946615299944964
Capitalized R&D asset: 14104340
ROCI (R&D-adjusted, %): -86.3910953158827
Rosenberg metric: -0.2637379940166903
FCF margin (%): -224.04442387783433
Revenue growth (%): -15.566148316011565
Rule of 40 score: -239.6105721938459
Financial ratios for KSCP — quarterly report dated 2025-03-31
Total revenue: 2917000
Gross profit: -668000
Operating income: -6828000
Net income: -6897000
Capital expenditures: 0
Operating cash flow: -6375000
Depreciation & amortization: 656000
Net tangible assets: 15080000
Owner earnings: -6241000
Return on net tangible assets (%): -41.38594164456234
Buffett classification: The Gruesome
Stock price: 2.82
Shares outstanding: 16916595
Book value: 18163000
P/B ratio: 2.6264822936739525
Market cap (USD): 47704797.9
Debt to equity: 0.30864945218300943
Current ratio: 2.272327964860908
Quick ratio: 2.058432051111407
Interest coverage ratio: -84.29629629629629
COGS to revenue (%): 122.90023997257455
R&D to revenue (%): 72.84881727802536
SG&A to revenue (%): 138.32704833733288
Free cash flow (dilution-adjusted): -6797000
Buyback yield (%): 0
Retained earnings: -200089000
Inventory turnover: 2.2308649657747357
Receivables turnover: 1.448361469712016
Capitalized R&D asset: 2125000
ROCI (R&D-adjusted, %): -22.157617448748397
FCF margin (%): -233.0133699005828
Rule of 40 score: -233.0133699005828
Financial ratios for KSCP — quarterly report dated 2025-06-30
Total revenue: 2749000
Gross profit: -918000
Operating income: -6257000
Net income: -6329000
Capital expenditures: 181000
Operating cash flow: -5490000
Depreciation & amortization: 639000
Net tangible assets: 12111000
Owner earnings: -5871000
Return on net tangible assets (%): -48.47659152836265
Buffett classification: The Gruesome
Stock price: 4.94
Shares outstanding: 16916595
Book value: 15115000
P/B ratio: 5.528811068475025
Market cap (USD): 83567979.30000001
Debt to equity: 0.4897122064174661
Current ratio: 1.895750142612664
Quick ratio: 1.6473188819167142
Interest coverage ratio: -85.71232876712328
COGS to revenue (%): 133.3939614405238
R&D to revenue (%): 76.35503819570752
SG&A to revenue (%): 117.86104037831939
Free cash flow (dilution-adjusted): -6056000
Buyback yield (%): 0
Retained earnings: -206418000
Inventory turnover: 2.1050516647531574
Receivables turnover: 1.1035728623042955
Capitalized R&D asset: 3522750
ROCI (R&D-adjusted, %): -21.631705255385096
Rosenberg metric: -0.11764705882352941
FCF margin (%): -220.29829028737723
Revenue growth (%): -5.7593417895097705
Rule of 40 score: -226.057632076887